This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-007068-vcfs41eb | why not the immunocompromised? |
| cord-002514-pp06m5xk | Antivirals for influenza: where now for clinical practice and pandemic preparedness? |
| cord-010570-ytv7dwr0 | Does intravenous immune globulin have a role in HIV- infected patients? |
| cord-281726-s1o5l7ns | Were there any alternative explanations for the particular pattern of distribution? |
| cord-007170-svsfu7fj | A possible etiological factor in human affective disorders? |
| cord-007170-svsfu7fj | Borna virus cDNA encoding a protein recognized by antibodies in humans with behavioral diseases Analysis of Borna disease virus- specific RNAs in infected cells and tissues Replication of Borna disease virus in cell cultures Influence of interferon on persistent infection caused by Borna disease virus in vitro Borna disease, a possible hazard for man? |
| cord-257553-479x7av6 | 95 Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: a case series Which preventive measures might protect health care workers from SARS? |
| cord-257553-479x7av6 | Early treatment improves outcomes in acute hepatitis C virus infection: a meta- analysis Two drugs or three? |
| cord-007047-7ty9mxa9 | 2 high- risk HPV DNA testing Occurrence and documentation of low- level bacteremia in a community hospital's patient population Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR Rapid diagnosis of tuberculous meningitis: what is the optimal method? |
| cord-007047-7ty9mxa9 | Diminishing racial disparities in early- onset neonatal group B streptococcal disease- United States Discovering new pathogens: culture- resistant bacteria Etiology of acute pharyngitis in children: is antibiotic therapy needed? |
| cord-266696-w9sb038q | Impaired in Patients with Severe Acute Respiratory Syndrome? |
| cord-266696-w9sb038q | w9sb038q nan Severe Acute Respiratory Syndrome? |
| cord-010578-uib9h1lb | A cluster of patients with a chronic mononucleosis- like syndrome: is Epstein- Barr virus the cause? |
| cord-010578-uib9h1lb | The chronic fatigue syndrome: a comprehensive approach to its definition and study Is chronic fatigue syndrome an infectious disease? |
| cord-279932-bilr71ay | ( SARS- CoV-2) is protective, and thus to accelerate its use? |
| cord-254183-98o0dssj | Xenotransplantation- associated infectious risk: a WHO consultation Rare and emerging viral infection in the transplant population Usutu virus infection in a patient who underwent orthotropic liver transplantation Viral metagenomics Viral discovery and sequence recovery using DNA microarrays Metagenomics and future perspectives in virus discovery From orphan virus to pathogen: the path to the clinical lab Next- generation sequencing and its applications in molecular diagnostics Virus identification in unknown tropical febrile illness cases using deep sequencing A new arenavirus in a cluster of fatal transplant- associated diseases History of discoveries and pathogenicity of TT viruses Human bocavirus: passenger or pathogen in acute respiratory tract infections? |
| cord-260274-c3586tp6 | A Cautionary Case Report Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| cord-260274-c3586tp6 | prospective cohort study The immunology of COVID-19: is immune modulation an option for treatment? |
| cord-273839-oasgagpc | Treatment failures and carriers: perception or problems? |
| cord-273839-oasgagpc | should culture be replaced? |
| cord-260779-riw5xs3j | convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-259243-1lkzcslx | And, would the use of SLGT2 inhibitors in non- diabetic patients improve clinical prognosis as well? |
| cord-259243-1lkzcslx | Hence, would diabetic patients with CVD and treated with SLGT2 inhibitors present a milder ARDS as compared to those with a different treatment? |
| cord-259243-1lkzcslx | Would they have a better clinical prognosis? |
| cord-279828-es498qul | Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-279828-es498qul | When less is better Why Are n't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019( COVID-19)? |
| cord-266232-2ctfmjb8 | key: cord-266232- 2ctfmjb8 authors: Trubiano, Jason A; Vogrin, Sara; Kwong, Jason C; Holmes, Natasha E title: Alterations in smell or taste – Classic COVID-19? |
| cord-265006-m1dmgcd1 | Time to change practice or keep gathering data? |
| cord-265006-m1dmgcd1 | title: Do the meta- analyses provide a clean bill of health to the use of renin- angiotensin system inhibitors in COVID-19? |
| cord-275454-an8xvow3 | ( SARS- CoV-2) Screening With Specimen Pools: Time to Swim, or Too Deep for Comfort? |
| cord-275454-an8xvow3 | This leads to a second and possibly more important question: what does a negative or positive result mean? |
| cord-288558-rthnj6wd | what are the clinical distinctions from secondary infection? |
| cord-267152-m9m0aunk | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-251945-v077hhgk | Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? |
| cord-258724-1qhen1bj | Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-265242-y8t37p0b | Global update on SARS cases Faster … but fast enough? |
| cord-287923-ev93r09i | The burden of healthcare- associated infections in Southeast Asia: a systematic literature review and meta- analysis European and Asian guidelines on management and prevention of catheter- associated urinary tract infections Feasibility and efficacy of infection- control interventions to reduce the number of nosocomial infections and drug- resistant microorganisms in developing countries: what else do we need? |
| cord-280954-wd89nka9 | : Do emergency providers consider RSV as an admission diagnosis? |
| cord-280954-wd89nka9 | development and validation Oseltamivir prescribing in pharmacy- benefits database Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease Respiratory syncytial virus- induced pulmonary disease and exacerbation of allergic asthma Antiviral immune responses and lung inflammation after respiratory syncytial virus infection Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease Respiratory syncytial virus infection in adults Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high- risk adults possible? |
| cord-281418-mvgp6qfv | : the respiratory viruses connection: myth or reality? |
| cord-287119-eo0evoog | The prevalence of HIV among adults with pulmonary TB at a population level in Zambia Tuberculosis transmission during the subclinical period: could unrelated cough play a part? |
| cord-254458-bbcef8xt | : Should We Put Our Money Where Our Mouth Is? |
| cord-254458-bbcef8xt | Presumed Asymptomatic Carrier Transmission of COVID-19 Coronavirus Clue? |
| cord-295270-6ptaxg74 | authors: Titanji, Boghuma K; Farley, Monica M; Schinazi, Raymond F; Marconi, Vincent C title: Response to Correspondence: Baricitinib – Impact on COVID-19 Coagulopathy? |
| cord-007321-7gi6xrci | A placebo- controlled, double- blind trial of erythromycin in adults with acute bronchitis Role of infection in chronic bronchitis Antibiotictherapy in exacerbations of chronic obstructive pulmonary disease Community- acquired pneumonia and acutebronchitis Prospective study of the aetiology and outcome of pneumonia in the community Howcommonis legionnaire's disease? |
| cord-007321-7gi6xrci | Does penicillin make Johnny's strep throat better? |
| cord-007321-7gi6xrci | Information about concentrations? |
| cord-297612-swc2pitd | What lessons it might teach us? |
| cord-299499-66qh3r75 | : a metaanalysis Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-298539-yncda1us | When will be the resumption of work in Wuhan and its surrounding areas during COVID-19 epidemic? |
| cord-296631-43z3ee8m | Time to change practice or keep gathering data? |
| cord-299720-f0ny4ur5 | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-259471-lsdodl0a | Protecting health care workers during the COVID-19 coronavirus outbreak: lessons from Taiwan's SARS response Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-259471-lsdodl0a | key: cord-259471-lsdodl0a authors: Pagliano, Pasquale; Piazza, Ornella; De Caro, Francesco; Ascione, Tiziana; Filippelli, Amelia title: Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019? |
| cord-307342-3gkiukh4 | Should Immigration Status Information Be Included in a Patient's Health Record? |
| cord-272956-0yumc7em | Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-272956-0yumc7em | What is the evidence? |
| cord-272956-0yumc7em | the cardiovascular system Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-300013-6m1f4q5r | Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus( COVID-19) Pneumonia? |
| cord-292372-kn27ghlv | What is meant by intention to treat analysis? |
| cord-292372-kn27ghlv | When does regression discontinuity design work? |
| cord-313693-qmkrn7pr | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-280571-ntgt5hy9 | : how can we test a test? |
| cord-280571-ntgt5hy9 | Why diagnose influenza in hospitalized pediatric patients? |
| cord-280571-ntgt5hy9 | hype or hope? |
| cord-299359-s8j78naz | Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices( ACIP) Vaccine Effectiveness Against Laboratory- confirmed Influenza in Healthy Young Children: A Case- Control Study Virus specificity of human influenza virus- immune cytotoxic T cells Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non- specific temporary immunity following infection Cytotoxic T- cell immunity to influenza Immunity to respiratory viruses Interference between outbreaks of respiratory syncytial virus and influenza infection Interference between outbreaks of epidemic viruses Does viral interference affect spread of influenza? |
| cord-279167-fj36mzm5 | ( strain TW AR) infection with wheezing, asthmatic bronchitis, and adult- onset asthma s principles and practice of infectious diseases Sinusitis: pathophysiology and treatment Nasal mucus weights in experimental rhinovirus infection Symptom expression in natural and experimental rhinovirus colds Sphenoid sinusitis: a review of 30 cases Radiological evaluation of Pott puffY tumor Allergic rhinitis or virus cold?: |
| cord-279167-fj36mzm5 | Does pseudoephedrine increase blood pressure in patients with controlled hypertension? |
| cord-279167-fj36mzm5 | The vulnerability of the nose to rhinovirus is shown by the fact that intranasal inoculation of virus in nonimmune volunteers routinely leads to a? 90% infection rate[ 37]. |
| cord-313617-hh7lccet | A molecular docking study Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? |
| cord-313617-hh7lccet | The Time Is Now to End the HIV Epidemic Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? |
| cord-327324-4c4a4bfz | Are there inferences that can be made from this very detailed study of susceptibility to tuberculosis conferred by diabetes? |
| cord-320562-zvsf3va0 | What comes next for TB control? |
| cord-303240-tv1ta3z5 | The study by Rosenberg et al., prompts the question: Can technology, electronic medical records, and other innovative strategies( like at- home testing or selfcollection of specimens) be leveraged alongside existing public health infrastructure to improve the efficiency, reach, and impact of larger- scale test and trace initiatives? |
| cord-313499-8ijbesl8 | For example, if someone is found to be serologically positive, should a follow up NAT test be performed to determine if the individual is shedding virus? |
| cord-317823-ztawznod | How much would closing schools reduce transmission during an influenza pandemic? |
| cord-314489-e5r5s5ee | Quo vadis? |
| cord-314489-e5r5s5ee | What did we learn over the last 20 years? |
| cord-316970-n2dly3oa | Why does Japan have so few cases of COVID-19? EMBO |
| cord-305394-wwabxlgr | COVID-19: Shining the Light on Africa Tackling COVID-19: Can the African continent play the long game? |
| cord-305394-wwabxlgr | What does this data mean for the rest of Africa? |
| cord-326494-qhxlh43t | So, what of pregnancy and TB? |
| cord-326494-qhxlh43t | What could antisepsis, 1,2 immunosuppressive therapy, 3 prevention of transfusion reaction, 4 elimination of pediatric syphilis and AIDS, 5 prevention of diabetes sequellae, 6 and prevention of birth defects 7 all possibly have in common? |
| cord-252423-ojmt4k2w | A few more days? cord-252423-ojmt4k2w Daddy, when are you going home? |
| cord-252423-ojmt4k2w | Given a high Angiotensin- converting enzyme 2( ACE2) level in heart, would the virus attack the heart and cause viral myocarditis? |
| cord-252423-ojmt4k2w | How many more days exactly?! |
| cord-252423-ojmt4k2w | Is it possible that I would become a long- term carrier of this new coronavirus？Would I be discriminated against? |
| cord-252423-ojmt4k2w | Or was it due to a lack of proper immune responses? |
| cord-252423-ojmt4k2w | Was it due to that COVID-19 is severer than other infectious diseases such as seasonal flu? |
| cord-252423-ojmt4k2w | Would it lead to cardiopulmonary sequelae? |
| cord-322082-80ym2rsq | How can neuraminidase- based immunity contribute to better influenza virus vaccines? |
| cord-322082-80ym2rsq | influenza viruses circulating in humans What is a pandemic? |
| cord-331731-c2r0kfaz | key: cord-331731-c2r0kfaz authors: Anugwom, Chimaobi M; Aby, Elizabeth S; Debes, Jose D title: Inverse association between chronic hepatitis B infection and COVID-19: immune- exhaustion or coincidence? |
| cord-324007-hapzf0fl | Does this patient have influenza? |
| cord-324007-hapzf0fl | McGeer, Allison J. title: Diagnostic Testing or Empirical Therapy for Patients Hospitalized with Suspected Influenza: What to Do? |
| cord-324007-hapzf0fl | The question becomes, what data do we have on the impact of antiviral therapy for the treatment of influenza in patients requiring hospitalization? |
| cord-333943-9d93na7s | Coronavirus disease( COVID-19) Situation Dashboard Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16- 23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact- tracing study Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-330742-m5xx8861 | The gendered dimensions of COVID-19 Disparities in age- specific morbidity and mortality from SARS- CoV-2 in China and the Republic of Korea Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-340956-1t3o24u5 | Weighing serological evidence of human exposure to animal influenza viruses− a literature review Review of influenza A virus in swine worldwide: a call for increased surveillance and research Swine workers and swine influenza virus infections Are swine workers in the United States at increased risk of infection with zoonotic influenza virus? |
| cord-322650-q8inhgtr | A real- time PCR for SARS- coronavirus incorporatingtarget gene pre- amplification Boosting the sensitivity of real- time PCR SARS detection by simultaneous reverse transcription and target gene pre- amplification Severe acute respiratory syndrome: relapse? |
| cord-322650-q8inhgtr | Hospital infection? |
| cord-290133-4ou7ubb4 | Even if it can remain aerosolized and viable for a prolonged period of time, just how infectious is it by this route? |
| cord-290133-4ou7ubb4 | If it can be aerosolized, for how long does it remain viable, and how far can it be carried? |
| cord-290133-4ou7ubb4 | In vitro activity of potential anti- poxvirus agents Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox Smallpox: anything to declare? |
| cord-290133-4ou7ubb4 | Is the N95 respirator appropriate for occupational protection against SARS? |
| cord-290133-4ou7ubb4 | The case for voluntary smallpox vaccination Smallpox and smallpox vaccination The 1972 smallpox outbreak in Khulna Municipality, Bangladesh Can postexposure vaccination against smallpox succeed? |
| cord-290133-4ou7ubb4 | The questions are these:( 1) Can smallpox virus be aerosolized? |
| cord-345045-nlui9d6e | A mismatch between the educational pipeline and public health workforce: can it be reconciled? |
| cord-341838-lkz8ro90 | Do people living with HIV experience greater age advancement than their HIV- negative counterparts? |
| cord-331978-y4uo7o8g | Once- in- a- Century Pandemic? |
| cord-331978-y4uo7o8g | So again, how do we prepare to fight COVID-19? |
| cord-331978-y4uo7o8g | What will be required to fight this novel virus as it travels the globe? |
| cord-346502-x2b0ao3q | What are the possible explanations for lack of clinical and virological benefit? |
| cord-350686-q2bu7o4i | However, this research[ 1] and similar research of others[ 2][ 3] missed answering a very important question: How does one choose the most efficient pool size relative to SARS- CoV-2 prevalence in samples? |
| cord-350338-lcsa06gm | Outbreak of COVID-19-an urgent need for good science to silence our fears? |
| cord-348350-pac9ha4q | COVID-19 Patients Chloroquine: a review Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate Pharmacokinetics and lung distribution of macrolide antibiotics in sepsis model rats Steady- state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults Hydroxychloroquine for treatment of SARS- CoV-2 infection? |
| cord-331465-humpwwk2 | But, in the context of COVID-19, what should we expect from a vaccine that in older and other high risk groups will likely experience a 40% or higher failure rate? |
| cord-331465-humpwwk2 | But, what type of protection can we realistically expect to achieve from vaccines and when? |
| cord-331465-humpwwk2 | Will the vaccine nevertheless help mitigate disease and prevent hospitalization, mechanical ventilation, or even transmission in those who still get infected? |
| cord-351231-aoz5jbf1 | The spirochetal etiology of Lyme disease Interview with Willie Bergdorfer, Ph.D. Interview by Vicki Glaser Lyme disease- a tick- borne spirochetosis? |
| cord-336563-hwemigk7 | A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Medication patterns and disease progression among 165 patients with coronavirus disease 2019( COVID-19) in Wuhan, China: a single- centered, retrospective, observational study Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease SARS: systematic review of treatment effects Effective treatment of severe COVID-19 patients with Tocilizumab Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study ACTEMRA ®( tocilizumab) injection, for intravenous or subcutaneous use Interleukin-6 and cytochrome- P450, reason for concern? |
| cord-336563-hwemigk7 | Should ACE and ARB's for hypertension be stopped in patients infected with COVID19? |
| cord-336563-hwemigk7 | Should NSAIDS be stopped in patients infected with COVID-19? |
| cord-355734-pz64534w | medRxiv Analysis of the infection status of the health care workers in Wuhan during the COVID-19 outbreak: A cross- sectional study SARS- CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients Deaths from COVID-19 in healthcare workers in Italy- What can we learn? |
| cord-354011-v9t2b2ca | Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination Influenza and the Hajj: defining influenza- like illness clinically Simultaneous detection of influenza viruses A and B using real- time quantitative PCR Pandemic A(H1N1)2009 influenza virus detection by real time RT- PCR: is viral quantification useful? |
| cord-315180-itvc86cv | Global health policy and neglected tropical diseases: then, now, and in the years to come Neglected tropical diseases, neglected communities, and conflict: how do we leave no one behind? |
| cord-315180-itvc86cv | Insights from mathematical models How can onchocerciasis elimination in Africa be accelerated? |
| cord-315180-itvc86cv | Lymphatic filariasis and onchocerciasis Are alternative strategies required to accelerate the global elimination of lymphatic filariasis? |
| cord-315180-itvc86cv | No HIV stage is dominant in driving the HIV epidemic in sub- Saharan Africa HIV treatment as prevention: debate and commentary- will early infection compromise treatment- as- prevention strategies Health- seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent Policy recommendations from transmission modeling for the elimination of visceral leishmaniasis in the Indian subcontinent Chagas disease Back- calculating the incidence of infection of leprosy in a Bayesian framework Innovative tools and approaches to end the transmission of Mycobacterium leprae Global leprosy update, 2016: accelerating reduction of disease burden Policy lessons from quantitative modeling of leprosy Human African trypanosomiasis Assessing strategies against Gambiense sleeping sickness through mathematical modeling Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar Complementary paths to chagas disease elimination: the impact of combining vector control with etiological treatment Optimisation of mass chemotherapy to control soil- transmitted helminth infection Soil- transmitted helminth infections Human schistosomiasis Investigating the effectiveness of current and modified WHO guidelines for the control of soil- transmitted helminth infections Are we on our way to achieving the 2020 goals for schistosomiasis morbidity control using current WHO guidelines? |
| cord-315180-itvc86cv | The global burden of disease study 2013: What does it mean for the NTDs? |
| cord-315180-itvc86cv | What Have We Learned From Quantitative Analysis and Transmission Modeling? |
| cord-353862-7xe3fvd5 | ( COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention 2019-nCoV epidemic: what about pregnancies? |
| cord-353862-7xe3fvd5 | Reuters Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding What are the risks of COVID-19 infection in pregnant women? |
| cord-354009-1ek4s8oe | China's COVID-19 strategy work elsewhere? |
| cord-354009-1ek4s8oe | How will countrybased mitigation measures influence the course of the COVID-19 epidemic? |
| cord-355618-7kfxc2w1 | How and why does this hesitancy shift from physician- guided acceptance of vaccines to their refusal? |
| cord-355618-7kfxc2w1 | With several vaccine candidates already being tested in clinical trials, we pose the question: what will the vaccine hesitant do in the face of this pandemic? |
| cord-352837-a29d5dkv | A/ H1N1: what else is out there? |
| cord-352837-a29d5dkv | High incidence of active cytomegalovirus infection among septic patients Sepsis and cytomegalovirus: foes or conspirators? |
| cord-352837-a29d5dkv | How Deep Need We Go? |
| cord-292094-vmsdhccp | : a meta- analysis Is the lateral decubitus radiograph necessary for the management of a parapneumonic pleural effusion? |
| cord-292094-vmsdhccp | A framework for improvement Do guidelines for community- acquired pneumonia improve the cost- effectiveness of hospital care? |
| cord-292094-vmsdhccp | How should we make the admission decision in community- acquired pneumonia? |
| cord-292094-vmsdhccp | Predicting bacteremia in patients with community- acquired pneumonia Diagnosing pneumonia by physical examination: relevant or relic? |
| cord-292094-vmsdhccp | The burden of community- acquired pneumonia in seniors: results of a population- based study Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995- 1997 Guidelines for community- acquired pneumonia: are they reflected in practice? |
| cord-292094-vmsdhccp | What factors influence physicians'decisions to switch from intravenous to oral antibiotics for community- acquired pneumonia? |
| cord-292094-vmsdhccp | Why do n't physicians follow clinical practice guidelines? |
| cord-292094-vmsdhccp | an international derivation and validation study Community- acquired pneumonia requiring hospitalization: 5-year prospective study outcome and prognostic factors in community- acquired pneumonia requiring hospitalization Appropriateness of hospitalization of patients with community- acquired pneumonia Assessing prognosis and selecting an initial site of care for adults with community- acquired pneumonia Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial Community acquired pneumonia: aetiology and usefulness of severity criteria on admission Use of prognostic scoring and outcome assessment tools in the admission decision for community- acquired pneumonia Assessment of illness severity in community acquired pneumonia: a useful new prediction tool? |
| cord-292094-vmsdhccp | analysis of two double- blind studies of patients with methicillin- resistant Staphylococcus aureus nosocomial pneumonia Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression American Thoracic Society/ Centers for Disease Control and Prevention/ Infectious Diseases Society of America: controlling tuberculosis in the United States Anti- inflammatory effects of macrolides- an underappreciated benefit in the treatment of community- acquired respiratory tract infections and chronic inflammatory pulmonary conditions? |
| cord-292094-vmsdhccp | implications for the treatment of patients with community- acquired pneumonia Streptococcus pneumoniae in community- acquired pneumonia: how important is drug resistance? |
| cord-317092-5qba9jiq | Can children respond most effectively to this vaccine, and will infancy be the optimal timing to achieve lifelong protection? |
| cord-317092-5qba9jiq | Can we leverage understanding of protective pediatric immunity and pathophysiology to guide design of therapeutic targets and vaccines? |
| cord-317092-5qba9jiq | How soon can we include vulnerable populations including pregnant women, neonates, and children in the vaccine development process to optimally tailor vaccine design to these populations? |
| cord-317092-5qba9jiq | In which target population will the vaccine be most effective and durable? |
| cord-317092-5qba9jiq | True or false? |
| cord-317092-5qba9jiq | What will be the effect of pre- existing immunity and maternal antibody on the vaccine? |
| cord-317092-5qba9jiq | Will antivirals suppress viral load in vivo as well as lower clinical pathology? |
| cord-318204-t024w7h6 | : Is there one? |
| cord-318204-t024w7h6 | A c c e p t e d M a n u s c r i p t 12 Is there a correlation between age and antibody titer? |
| cord-318204-t024w7h6 | Are quantitative serologies helpful? |
| cord-318204-t024w7h6 | Are serologic tests useful to diagnose acute COVID-19? |
| cord-318204-t024w7h6 | Does a positive antibody test mean that a patient is immune? |
| cord-318204-t024w7h6 | Does a positive specimen mean that a patient is infectious? |
| cord-318204-t024w7h6 | Is it worth repeating a test after a patient has tested negative? |
| cord-318204-t024w7h6 | Is point- of- care testing available? |
| cord-318204-t024w7h6 | negative? |
| cord-318204-t024w7h6 | useful? |